VANGL2 and B-cell chronic lymphocytic leukemia: VANGL2 upregulated in B lymphocytes of chronic lymphocytic leukaemia (CLL) patients, and levels of Wnt/PCP-related proteins accumulate in the late stage of the disease, indicating the crucial role of Wnt/PCP pathway in CLL cell migration and transendothelial invasion (10).